Results 101 to 110 of about 157,713 (224)
Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan [PDF]
D. Dunbar Ivy+4 more
openalex +1 more source
Abstract Aims Iron is essential to maintain cellular energy metabolism in the myocardium. Impaired cellular iron availability negatively affects myocardial physiology and can aggravate heart failure (HF). Iron deficiency (ID) is frequently found in patients with acute and chronic HF (AHF, CHF) and associated with clinical outcome.
Lukas Lanser+11 more
wiley +1 more source
Abstract Aims The last released European guidelines on the management of heart failure (HF) recommend in patients with chronic HF with reduced ejection fraction (HFrEF) a pharmacological approach based on four fundamental drugs to be rapidly implemented and then uptitrated to modify disease progression.
Stefania Paolillo+62 more
wiley +1 more source
Hyperuricemia as a prognostic factor in pulmonary arterial hypertension
Danielle Bendayan+5 more
openalex +1 more source
Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension [PDF]
Martijn C. Post+3 more
openalex +1 more source
Abstract Aims Biomarkers are pivotal in the management of heart failure (HF); however, their lack of cardiac specificity could limit clinical utility. This study aimed to investigate the transcoronary changes and intracardiac production of these biomarkers.
Jie Ren+10 more
wiley +1 more source
Predictors of Outcomes in Pediatric Pulmonary Arterial Hypertension. [PDF]
Pradana AD.
europepmc +1 more source
Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis [PDF]
C. Gregory Elliott
openalex +1 more source
Abstract Background Chronic kidney disease (CKD) has a high prevalence in patients with heart failure (HF) and is associated with prolonged hospitalization, increased need for intensive care and mortality. There is an urgent need to identify factors that influence the interaction between heart and kidney disorders, often described as cardiorenal ...
Alexander Reinecke+7 more
wiley +1 more source